Current Pharmaceutical Biotechnology

Editor-in-Chief:

Davide Prosperi
Department of Biotechnology and Bioscience
University of Milan Bicocca
Milano
Italy

Back

Become EABM
Become Reviewer

Editorial promotion: free to download

Volume:2   Issue: 4
Pp: i-i
Antonio J. Grillo-Lopez, Anne McClure and Brian K. Dallaire
DOI: 10.2174/1389201013378554

Non-Hodgkins Lymphoma: Review of Conventional Treatments

Volume:2   Issue: 4
Pp: 279-291
P. Multani, C.A. White and A. Grillo-Lopez
DOI: 10.2174/1389201013378581

Monoclonal Antibodies: A New Era in the Treatment of Non-Hodgkins Lymphoma

Volume:2   Issue: 4
Pp: 301-311
A. J. Grillo-Lopez, B.K. Dallaire, A. McClure, R. Weaver, C. Varns, A. Wei, R. Allen, D. Lee, D. Shen, J. Leonard, P.Multani and C.A.White
DOI: 10.2174/1389201013378563

Toxin-Labeled Monoclonal Antibodies

Volume:2   Issue: 4
Pp: 313-325
R.J. Kreitman
DOI: 10.2174/1389201013378635

Radioimmunotherapy of B-Cell NHL

Volume:2   Issue: 4
Pp: 327-339
R.F. Meredith and S.J. Knox
DOI: 10.2174/1389201013378590

Antibody Therapy of Acute and Chronic Leukemias

Volume:2   Issue: 4
Pp: 357-367
Spero R. Cataland, Margaret Lucas and John C. Byrd
DOI: 10.2174/1389201013378608

Future Approaches for Treating Hematologic Disease

Volume:2   Issue: 4
Pp: 369-382
M. Reff, G. Braslawsky and N. Hanna
DOI: 10.2174/1389201013378626